Our Governance

The mission of the Company is to conduct clinical trial research to improve treatment of Bladder, Kidney, Testicular, Penile and Prostate Cancers.

We aim to develop, foster and promote prostate and urogenital cancer research by

  • providing access to clinical trials for all appropriate Australian and New Zealand patients
  • increasing involvement of and collaboration with various professional disciplines in clinical and preclinical research
  • providing opportunities for clinical research
  • building systems to simplify and streamline clinical research of the highest quality
  • fostering a culture of research amongst all clinicians involved in the care of patients with urogenital cancers
  • providing training opportunities for the next generation of clinical researchers
  • providing for translational studies in prostate and other urogenital cancers, including tissue banking from clinical trials for further studies